Teriflunomide Tablet, Film Coated
Product Images NDC 68254-5013

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 68254-5013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Concord Biotech Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (A2c399e2 Baba 441a 8598 Bc8fa0e4dad9 01)

Chemical structure of teriflunomide depicting its molecular formula with a trifluoromethyl-substituted phenyl group and an amide, hydroxyl, and nitrile functional groups.*

FDA Label Image

Figure 1: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 1) (A2c399e2 Baba 441a 8598 Bc8fa0e4dad9 02)

A line graph showing disability progression sustained for 12 weeks (%) over time (weeks) comparing placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide. The graph includes curves for each group and a table of numbers at risk at various weeks.*

FDA Label Image

Figure 2: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 2) (A2c399e2 Baba 441a 8598 Bc8fa0e4dad9 03)

A Kaplan-Meier plot showing the percentage of disability progression sustained over 12 weeks across 108 weeks for placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The graph includes lines representing each group and a table of the number of patients at risk over time. Statistical significance is noted for the 14 mg Teriflunomide versus placebo comparison.*

FDA Label Image

Image (A2c399e2 Baba 441a 8598 Bc8fa0e4dad9 04)

Label for Teriflunomide Tablets 7 mg by Concord Biotech Limited. The label indicates the product is prescription only, contains 30 tablets, and specifies dosage instructions as one tablet orally once daily. Storage conditions are 20° to 25°C with permitted excursions to 15° to 30°C. Includes NDC 68254-5009-1 and manufacturer address in Ahmedabad, Gujarat, India.*

FDA Label Image

Image (A2c399e2 Baba 441a 8598 Bc8fa0e4dad9 05)

Label for Teriflunomide Tablets 14 mg by Concord Biotech Limited. The label includes dosage information for 14 mg strength, storage instructions, a barcode, and a package count of 30 tablets. It also provides manufacturing details including the license number and facility address in Gujarat, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.